| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | "1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of BMP5 mRNA" | 28903501 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA" | 27188386 |
| D000111 | Acetylcysteine | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BMP5 mRNA | 22129741 |
| D020106 | Acrylamide | Acrylamide results in decreased expression of BMP5 mRNA | 28959563 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased methylation of BMP5 gene | 27153756 |
| D001151 | Arsenic | Arsenic results in decreased expression of BMP5 mRNA | 19654921 |
| C487081 | belinostat | belinostat results in increased expression of BMP5 mRNA | 26272509 |
| C487081 | belinostat | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA" | 27188386 |
| D004958 | Estradiol | Estradiol affects the expression of BMP5 mRNA | 14699072 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of BMP5 mRNA | 25181051 |
| C006780 | bisphenol A | bisphenol A results in increased methylation of BMP5 gene | 28505145 |
| D001966 | Bromine | Bromine results in decreased expression of BMP5 mRNA | 18790026 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of BMP5 mRNA | 27375191 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of BMP5 mRNA | 17484886 |
| D002330 | Carmustine | BMP5 mRNA affects the susceptibility to Carmustine | 16365179 |
| D002699 | Chlorambucil | Chlorambucil results in increased mutagenesis of BMP5 gene | 10517996 |
| D020245 | p-Chloromercuribenzoic Acid | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA" | 27188386 |
| D020245 | p-Chloromercuribenzoic Acid | p-Chloromercuribenzoic Acid results in increased expression of BMP5 mRNA | 26272509 |
| D002737 | Chloroprene | Chloroprene results in decreased expression of BMP5 mRNA | 23125180 |
| D004390 | Chlorpyrifos | Chlorpyrifos results in decreased expression of BMP5 mRNA | 21356183 |
| D004390 | Chlorpyrifos | [Copper co-treated with Chlorpyrifos] results in decreased expression of BMP5 mRNA | 21356183 |
| D003300 | Copper | [Copper co-treated with Chlorpyrifos] results in decreased expression of BMP5 mRNA | 21356183 |
| D003375 | Coumestrol | [Coumestrol co-treated with resveratrol] results in increased expression of BMP5 mRNA | 19167446 |
| D003561 | Cytarabine | Cytarabine results in decreased expression of BMP5 mRNA | 21198554 |
| C014347 | decitabine | decitabine results in decreased expression of BMP5 mRNA | 27915011 |
| D004041 | Dietary Fats | Dietary Fats results in decreased expression of BMP5 mRNA | 18042831|1845759 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of BMP5 mRNA | 24535843 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in decreased expression of BMP5 mRNA | 24535843 |
| D004052 | Diethylnitrosamine | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BMP5 mRNA | 22129741 |
| D052244 | Endocrine Disruptors | Endocrine Disruptors results in decreased expression of BMP5 mRNA | 25198161 |
| C118739 | entinostat | entinostat results in increased expression of BMP5 mRNA | 26272509|2718838 |
| C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA" | 27188386 |
| D005038 | Ethylnitrosourea | Ethylnitrosourea results in increased mutagenesis of BMP5 gene | 10517996|9475716 |
| C089796 | hexabromocyclododecane | hexabromocyclododecane affects the expression of BMP5 mRNA | 24680724 |
| C016517 | indole-3-carbinol | indole-3-carbinol affects the expression of BMP5 mRNA | 21396975 |
| C016517 | indole-3-carbinol | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of BMP5 mRNA | 22129741 |
| C011890 | kojic acid | kojic acid results in decreased expression of BMP5 mRNA | 16595896 |
| C042720 | mercuric bromide | mercuric bromide results in increased expression of BMP5 mRNA | 26272509 |
| C042720 | mercuric bromide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA" | 27188386 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of BMP5 mRNA | 28001369 |
| D008770 | Methylnitrosourea | Methylnitrosourea results in increased mutagenesis of BMP5 gene | 10517996|1717435 |
| D015655 | 1-Methyl-4-phenylpyridinium | 1-Methyl-4-phenylpyridinium results in decreased expression of BMP5 mRNA | 24810058 |
| C043243 | methyl tert-butyl ether | methyl tert-butyl ether affects the expression of BMP5 mRNA | 24128854 |
| C091888 | monoisoamyl-2,3-dimercaptosuccinate | "monoisoamyl-2,3-dimercaptosuccinate results in increased expression of BMP5 mRNA" | 19615344 |
| D009151 | Mustard Gas | Mustard Gas results in decreased expression of BMP5 mRNA | 18988085 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in decreased expression of BMP5 mRNA" | 25554681 |
| C030110 | oxaliplatin | [oxaliplatin co-treated with Topotecan] results in increased expression of BMP5 mRNA | 25729387 |
| D000073878 | Palm Oil | Palm Oil results in decreased expression of BMP5 mRNA | 18042831 |
| C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA" | 27188386 |
| C496932 | panobinostat | panobinostat results in increased expression of BMP5 mRNA | 26272509 |
| D010634 | Phenobarbital | [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of BMP5 mRNA | 24535843 |
| D010634 | Phenobarbital | Phenobarbital affects the expression of BMP5 mRNA | 23091169 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in increased expression of BMP5 mRNA | 26272509 |
| C006253 | pirinixic acid | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of BMP5 mRNA | 19710929 |
| D011192 | Potassium Dichromate | Potassium Dichromate results in increased expression of BMP5 mRNA | 23608068 |
| D011374 | Progesterone | Progesterone affects the expression of BMP5 mRNA | 21291521 |
| D011374 | Progesterone | NCOA2 protein affects the reaction [Progesterone results in decreased expression of BMP5 mRNA] | 17556502 |
| D011374 | Progesterone | PGR protein affects the reaction [Progesterone results in decreased expression of BMP5 mRNA] | 17556502 |
| D011374 | Progesterone | Progesterone results in decreased expression of BMP5 mRNA | 17556502 |
| C059514 | resveratrol | [Coumestrol co-treated with resveratrol] results in increased expression of BMP5 mRNA | 19167446 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [BMP5 protein results in increased expression of DKK1 mRNA] | 15242789 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [BMP5 protein results in increased expression of FGFR3 mRNA] | 15242789 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [BMP5 protein results in increased expression of SNAI1 mRNA] | 15242789 |
| C009277 | sodium arsenate | sodium arsenate results in increased expression of BMP5 mRNA | 21795629 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of BMP5 mRNA | 19615344 |
| D053260 | Soot | Soot results in decreased expression of BMP5 mRNA | 26551751 |
| D013629 | Tamoxifen | Tamoxifen affects the expression of BMP5 mRNA | 14699072 |
| C047246 | temozolomide | BMP5 mRNA affects the susceptibility to temozolomide | 16365179 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of BMP5 mRNA | 24035824|2629044 |
| D013750 | Tetrachloroethylene | Tetrachloroethylene results in increased expression of BMP5 mRNA | 28973375 |
| D019772 | Topotecan | [oxaliplatin co-treated with Topotecan] results in increased expression of BMP5 mRNA | 25729387 |
| C012589 | trichostatin A | trichostatin A results in decreased expression of BMP5 mRNA | 15901671 |
| C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA" | 27188386 |
| C012589 | trichostatin A | trichostatin A results in increased expression of BMP5 mRNA | 24935251|2627250 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of BMP5 mRNA | 15901671 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid results in decreased methylation of BMP5 gene | 29154799 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of BMP5 mRNA | 23179753|2438349 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of BMP5 mRNA | 24896083 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in decreased methylation of BMP5 gene | 25560391 |
| C025643 | vinclozolin | vinclozolin results in increased expression of BMP5 mRNA | 22615374 |
| C111237 | vorinostat | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BMP5 mRNA" | 27188386 |
| C111237 | vorinostat | vorinostat results in increased expression of BMP5 mRNA | 26272509|2718838 |
| D014874 | Water Pollutants, Chemical | "Water Pollutants, Chemical results in decreased expression of BMP5 mRNA" | 25198161 |